July 30, 2021 - ROSEN LOGO.jpg
AKBA FINAL DEADLINE FRIDAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action – AKBA
10 mai 2022 17h15 HE | The Rosen Law Firm PA
NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28,...
BL-new-logo.jpg
AKEBIA THERAPEUTICS, INC. (NASDAQ: AKBA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Akebia Therapeutics, Inc. (NASDAQ: AKBA)
10 mai 2022 01h35 HE | Bernstein Liebhard LLP
NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important May 13 Deadline in Securities Class Action – AKBA
03 mai 2022 15h00 HE | The Rosen Law Firm PA
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28,...
BL-new-logo.jpg
AKEBIA THERAPEUTICS, INC. (NASDAQ: AKBA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Akebia Therapeutics, Inc. (NASDAQ: AKBA)
28 avr. 2022 00h30 HE | Bernstein Liebhard LLP
Did you lose money on investments in Akebia Therapeutics? If so, please visit Akebia Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TOP RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important May 13 Deadline in Securities Class Action – AKBA
27 avr. 2022 16h28 HE | The Rosen Law Firm PA
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AKBA
22 avr. 2022 16h05 HE | The Rosen Law Firm PA
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June 28,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKBA
18 avr. 2022 14h02 HE | The Rosen Law Firm PA
NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AKBA
12 avr. 2022 16h00 HE | The Rosen Law Firm PA
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AKBA
08 avr. 2022 13h00 HE | The Rosen Law Firm PA
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akebia Therapeutics, Inc. (NASDAQ: AKBA) between June...
BL-new-logo.jpg
AKEBIA THERAPEUTICS, INC. (NASDAQ: AKBA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Akebia Therapeutics, Inc. (NASDAQ: AKBA)
07 avr. 2022 06h15 HE | Bernstein Liebhard LLP
Did you lose money on investments in Akebia Therapeutics? If so, please visit Akebia Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...